MENOGENIX

menogenix-logo

MenoGeniX, Inc., a clinical stage biotechnology company, focuses on the development of drugs for menopause and the menopause-like symptoms that occur in breast and prostate cancer patients. The company was founded in 2010 and is based in Aurora, Colorado.

#SimilarOrganizations #People #Financial #Website #More

MENOGENIX

Industry:
Biotechnology Medical Medical Device

Founded:
2010-01-01

Address:
Aurora, Colorado, United States

Country:
United States

Website Url:
http://www.menogenix.com

Total Employee:
1+

Status:
Active

Contact:
+720-859-4080

Email Addresses:
[email protected]

Total Funding:
1.11 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Content Delivery Network Euro Typekit Squarespace Squarespace Add To Cart


Similar Organizations

dauntless-pharmaceuticals-logo

Dauntless Pharmaceuticals

Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

pharmacyte-biotech-logo

PharmaCyte Biotech

PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer.

phloronol-logo

Phloronol

Phloronol, a biotechnology company, explicates anti-oxidant metabolic benefits of polyphenols/phlorotannins, extracted from marine algae.

Current Employees Featured

debra-m-duke_image

Debra M. Duke
Debra M. Duke Founder, President, and CEO @ MenoGeniX
Founder, President, and CEO
2010-01-01

douglas-farrar_image

Douglas Farrar
Douglas Farrar Co-Founder @ MenoGeniX
Co-Founder

richard-c-duke_image

Richard C. Duke
Richard C. Duke Chairman @ MenoGeniX
Chairman
2010-06-01

woodruff-emlen_image

Woodruff Emlen
Woodruff Emlen Director, Acting Chief Medical Officer @ MenoGeniX
Director, Acting Chief Medical Officer

Founder


debra-m-duke_image

Debra M. Duke

douglas-farrar_image

Douglas Farrar

Investors List

national-institutes-of-health_image

National Institutes of Health

National Institutes of Health investment in Grant - MenoGeniX

Official Site Inspections

http://www.menogenix.com

  • Host name: 198.185.159.144
  • IP address: 198.185.159.144
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "MenoGeniX"

MenoGeniX

MenoGeniX is a privately-held, clinical stage biopharmaceutical company, dedicated to researching and developing a novel potential treatment for women suffering from hot flashes โ€ฆSee details»

About MenoGeniX

MenoGeniX is a clinical-stage biotech company dedicated to womenโ€™s health focused on developing a novel potential treatment for women suffering from hot flashes and related vasomotor symptoms of menopause.See details»

Management & Business Advisors โ€” MenoGeniX

Debra Duke is the president of MenoGeniX, which she co-founded in 2010. She has 30 years of business experience in the biotechnology and energy industries.See details»

MenoGeniX - Crunchbase Company Profile & Funding

MenoGeniX, Inc., a clinical stage biotechnology company, focuses on the development of drugs for menopause and the menopause-like symptoms that occur in breast and prostate cancer patients. The company was founded in โ€ฆSee details»

MenoGeniX Company Profile 2024: Valuation, Funding & Investors โ€ฆ

Developer of drugs designed to help women treat menopausal problems. The company's drugs treat hot flashes and related vasomotor symptoms of menopause and it offers hormone โ€ฆSee details»

Startup aims to cool hot flashes - UCHealth Today

Jan 24, 2017ย ยท Debra Duke founded MenoGeniX to bring a drug the FDA originally approved in 1991 to market โ€” this time to help women deal with menopausal hot flashes. Hot flashes are uncomfortable, theyโ€™re disruptive, โ€ฆSee details»

MenoGeniX, Inc - LinkedIn

MenoGeniX is a privately-held, clinical stage biopharmaceutical company, dedicated to researching and developing a novel potential treatment for women suffering from hot flashes โ€ฆSee details»

MenoGeniX - Org Chart, Teams, Culture & Jobs - The Org

View MenoGeniX's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

MenoGeniX - Contacts, Employees, Board Members, Advisors

MenoGeniX is a clinical stage biotechnology company focusing on the development of drugs for menopause.See details»

MenoGeniX - Funding, Financials, Valuation & Investors

MenoGeniX is a clinical stage biotechnology company focusing on the development of drugs for menopause.See details»

MenoGeniX - Overview, News & Similar companies | ZoomInfo.com

MenoGeniX. Manufacturing ยท Colorado, United States ยท <25 Employees. MenoGeniX is a clinical-stage biotech company dedicated to womens health focused on developing a novel potential โ€ฆSee details»

MENOGENIX, INC. Company Profile | Aurora, CO - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for MENOGENIX, INC. of Aurora, CO. Get the latest business insights from Dun & Bradstreet.See details»

Clinical Trials - MenoGeniX

MenoGeniX has completed a multicenter, double-blind, randomized, placebo-controlled Phase I clinical trial that evaluated the safety and effectiveness of MNGX-100 in treating hot flashes in โ€ฆSee details»

MenoGeniX Company Profile - Office Locations, Competitors

MenoGeniX is a clinical-stage biopharmaceutical company. It researches and develops a potential treatment for women suffering from hot flashes and related vasomotor symptoms of โ€ฆSee details»

MenoGeniX Inc. - insights.citeline.com

Apr 16, 2015ย ยท MenoGeniX is developing a repurposed form of filgrastim as a non-hormonal treatment for menopausal symptoms, including hot flashes. Having achieved clinically โ€ฆSee details»

NK3R antagonists: a novel approach for menopause symptoms

Sep 1, 2023ย ยท Now, studies have demonstrated that neurokinin 3 receptor antagonists have a level of effectiveness against vasomotor symptoms that is similar to that of hormone therapy. โ€ฆSee details»

Gladys Monroy - Business Advisor at MenoGeniX - The Org

MenoGeniX. Gladys Monroy; Gladys Monroy. Business Advisor at MenoGeniX. Contact. Dr. Gladys Monroy is a patent attorney specializing in the life sciences and has practiced patent โ€ฆSee details»

Contact โ€” MenoGeniX

12635 East Montview Blvd. Suite 100 Aurora, Colorado, USA 80045 [email protected]See details»

Abortion pill access requests surge from U.S., Canadian non-profit โ€ฆ

1 day agoย ยท The Canadian non-profit organization provides online consultation and medication for women around the world seeking abortion says it has seen a fourfold increase in U.S. โ€ฆSee details»

Scientific Advisors - MenoGeniX

Collaborative projects with other investigators at the University of Colorado Health Sciences Center (UCDHSC) include the role of sex hormones in body weight distribution at menopause โ€ฆSee details»

linkstock.net © 2022. All rights reserved